Shares of NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.00 and traded as high as $0.71. NovaBay Pharmaceuticals shares last traded at $0.65, with a volume of 231,570 shares trading hands.
NovaBay Pharmaceuticals Trading Up 2.4 %
The firm has a market capitalization of $2.80 million, a price-to-earnings ratio of -0.07 and a beta of 2.82.
NovaBay Pharmaceuticals Company Profile
NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.
Further Reading
- Five stocks we like better than NovaBay Pharmaceuticals
- What does consumer price index measure?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- What Are Dividend Contenders? Investing in Dividend Contenders
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- What Does Downgrade Mean in Investing?
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
